TriSalus Life Sciences, Inc.(TLSI US)
$2.85-0.3711.49%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -59.4 | -30.0 | -39.2 | -27.3 | |||||
| Depreciation & Amortization | 0.7 | 0.7 | 0.6 | 0.6 | |||||
| Stock Based Compensation | 1.4 | 5.4 | 9.1 | 10.0 | |||||
| Change in Working Capital | 0.5 | -9.5 | 2.1 | 0.8 | |||||
| Other Non-Cash Items | 6.2 | -7.4 | 9.4 | -4.0 | |||||
| Net Cash from Operating Activities | -50.6 | -40.8 | -18.0 | -20.0 | |||||
| -Investments in Property, Plant & Equipment | -0.6 | -0.3 | -0.9 | -0.3 | |||||
| -Acquisitions Net | - | - | 0.1 | 0.0 | |||||
| -Purchases of Investments | - | - | - | - | |||||
| Sales/Maturities of Investments | - | - | - | - | |||||
| Other Investing Activities | -1.0 | - | - | - | |||||
| Net Cash from Investing Activities | -1.6 | -0.3 | -0.8 | -0.3 | |||||
| Net Debt Issuance | -0.1 | 24.9 | 9.9 | -0.0 | |||||
| Net Stock Issuance | 9.2 | 15.5 | 22.9 | 65.2 | |||||
| -Net Dividends Paid | - | - | - | - | |||||
| Other Financing Activities | 45.5 | -2.5 | -2.1 | -1.8 | |||||
| Net Cash from Financing Activities | 54.6 | 37.9 | 30.8 | 63.5 | |||||
| Effect of Forex Changes | - | - | - | 0.4 | |||||
| Net Change in Cash | 2.5 | -3.3 | 11.9 | 43.6 | |||||
| Cash at End of Period | 12.1 | 8.9 | 20.8 | 126.9 | |||||
| Operating Cash Flow | -50.6 | -40.8 | -18.0 | -20.0 | |||||
| -Capital Expenditure | -0.6 | -0.3 | -0.9 | -0.3 | |||||
| Free Cash Flow | -51.2 | -41.2 | -18.9 | -20.3 | |||||
| Millions USD (ex. Per Share) | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -59.4 | -30.0 | -39.2 | -27.3 | |||||
| Depreciation & Amortization | 0.7 | 0.7 | 0.6 | 0.6 | |||||
| Stock Based Compensation | 1.4 | 5.4 | 9.1 | 10.0 | |||||
| Change in Working Capital | 0.5 | -9.5 | 2.1 | 0.8 | |||||
| Other Non-Cash Items | 6.2 | -7.4 | 9.4 | -4.0 | |||||
| Net Cash from Operating Activities | -50.6 | -40.8 | -18.0 | -20.0 | |||||
| -Investments in Property, Plant & Equipment | -0.6 | -0.3 | -0.9 | -0.3 | |||||
| -Acquisitions Net | - | - | 0.1 | 0.0 | |||||
| -Purchases of Investments | - | - | - | - | |||||
| Sales/Maturities of Investments | - | - | - | - | |||||
| Other Investing Activities | -1.0 | - | - | - | |||||
| Net Cash from Investing Activities | -1.6 | -0.3 | -0.8 | -0.3 | |||||
| Net Debt Issuance | -0.1 | 24.9 | 9.9 | -0.0 | |||||
| Net Stock Issuance | 9.2 | 15.5 | 22.9 | 65.2 | |||||
| -Net Dividends Paid | - | - | - | - | |||||
| Other Financing Activities | 45.5 | -2.5 | -2.1 | -1.8 | |||||
| Net Cash from Financing Activities | 54.6 | 37.9 | 30.8 | 63.5 | |||||
| Effect of Forex Changes | - | - | - | 0.4 | |||||
| Net Change in Cash | 2.5 | -3.3 | 11.9 | 43.6 | |||||
| Cash at End of Period | 12.1 | 8.9 | 20.8 | 126.9 | |||||
| Operating Cash Flow | -50.6 | -40.8 | -18.0 | -20.0 | |||||
| -Capital Expenditure | -0.6 | -0.3 | -0.9 | -0.3 | |||||
| Free Cash Flow | -51.2 | -41.2 | -18.9 | -20.3 | |||||